Recombinant Human CD44 Fc Chimera Protein, CF

Catalog # Availability Size / Price Qty
3660-CD-050
R&D Systems Recombinant Proteins and Enzymes
1 Image
Product Details
Citations (15)
FAQs
Supplemental Products
Reviews (2)

Recombinant Human CD44 Fc Chimera Protein, CF Summary

Product Specifications

Purity
>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its ability to bind biotinylated hyaluronan in a functional ELISA with an estimated Kd <0.6 nM.
Source
Mouse myeloma cell line, NS0-derived human CD44 protein
Human CD44
(Gln21-Pro220)
Accession # P16070
IEGRMD Human IgG1
(Pro100-Lys330)
N-terminus C-terminus
Accession #
N-terminal Sequence
Analysis
Gln21
Predicted Molecular Mass
48.6 kDa (monomer)
SDS-PAGE
72-86 kDa, reducing conditions

Product Datasheets

You must select a language.

x

3660-CD

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

3660-CD

Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution Reconstitute at 100 μg/mL in sterile PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: CD44

CD44 is a ubiquitously expressed protein that is the major receptor for hyaluronan and exerts control over cell growth and migration (1-3). Human CD44 has a 20 amino acid (aa) signal sequence, an extracellular domain (ECD) with a 100 aa hyaluronan-binding disulfide-stabilized link region and a 325-530 aa stem region, a 21 aa transmembrane domain, and a 72 aa cytoplasmic domain. Within the stem, ten variably spliced exons (v1-10, exons 6-15) produce multiple protein isoforms (1-3). The standard or hematopoietic form, CD44H, does not include the variable segments (1-3). Cancer aggressiveness and T cell activation have been correlated with expression of specific isoforms (1, 3). With variable N- and O-glycosylation and splicing within the stalk, CD44 can range from 80 to 200 kDa (1). Within the N-terminal invariant portion of the ECD (aa 21-220), human CD44 shares 76%, 76%, 86%, 83% and 79% identity with corresponding mouse, rat, equine, canine and bovine CD44, respectively. The many reported functions of CD44 fall within three categories (1). First, CD44 binds hyaluronan and other ligands within the extracellular matrix and can function as a “platform” for growth factors and metalloproteinases. Second, CD44 can function as a co-receptor that modifies activity of receptors including MET and the ERBB family of tyrosine kinases. Third, the CD44 intracellular domain links the plasma membrane to the actin cytoskeleton via the ERM proteins, ezrin, radixin and moesin. CD44 can be synthesized in a soluble form (4) or may be cleaved at multiple sites by either membrane-type matrix metalloproteinases, or ADAM proteases to produce soluble ectodomains (5, 6). The cellular portion may then undergo gamma secretase-dependent intramembrane cleavage to form an A beta -like transmembrane portion and a cytoplasmic signaling portion that affects gene expression (7, 8). These cleavage events are thought to promote metastasis by enhancing tumor cell motility and growth (1, 5).

References
  1. Ponta, H. et al. (2003) Nat. Rev. Mol. Cell Biol. 4:33.
  2. Screaton, G.R. et al. (1992) Proc. Natl. Acad. Sci. USA 89:12160.
  3. Lynch, K.W. (2004) Nat. Rev. Immunol. 4:931.
  4. Yu, Q. and B.P. Toole (1996) J. Biol. Chem. 271:20603.
  5. Nagano, O. and H. Saya (2004) Cancer Sci. 95:930.
  6. Nakamura, H. et al. (2004) Cancer Res. 64:876.
  7. Murakami, D. et al. (2003) Oncogene 22:1511.
  8. Lammich, S. et al. (2002) J. Biol. Chem. 277:44754.
Entrez Gene IDs
960 (Human); 12505 (Mouse); 25406 (Rat); 100126860 (Porcine)
Alternate Names
CD44 antigen; CD44 molecule (Indian blood group); CD44; CD44R; CDw44; cell surface glycoprotein CD44; chondroitin sulfate proteoglycan 8; CSPG8; ECMR-III; epican; Extracellular matrix receptor III; GP90 lymphocyte homing/adhesion receptor; HCAM; HCELL; hematopoietic cell E- and L-selectin ligand; Heparan sulfate proteoglycan; Hermes antigen; homing function and Indian blood group system; HUTCH-I; Hyaluronate receptor; IN; LHR; MC56; MDU2; MDU2CD44 antigen (homing function and Indian blood group system); MDU3; MDU3CDW44; MIC4; MIC4MGC10468; MUTCH-I; Pgp1; PGP-1; PGP-I; Phagocytic glycoprotein 1; Phagocytic glycoprotein I

Citations for Recombinant Human CD44 Fc Chimera Protein, CF

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

15 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Modulation of galectin-9 mediated responses in monocytes and T-cells by pregnancy-specific glycoprotein 1
    Authors: Mendoza, M;Ballesteros, A;Rendon-Correa, E;Tonk, R;Warren, J;Snow, AL;Stowell, SR;Blois, SM;Dveksler, G;
    The Journal of biological chemistry
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  2. Clinical Staphylococcus aureus inhibits human T-cell activity through interaction with the PD-1 receptor
    Authors: Mellergaard, M;Skovbakke, SL;Jepsen, SD;Panagiotopoulou, N;Hansen, ABR;Tian, W;Lund, A;Høgh, RI;Møller, SH;Guérillot, R;Hayes, AS;Erikstrup, LT;Andresen, L;Peleg, AY;Larsen, AR;Stinear, TP;Handberg, A;Erikstrup, C;Howden, BP;Goletz, S;Frees, D;Skov, S;
    mBio
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry Control
  3. Advanced bioactive glue tethering Lubricin/PRG4 to promote integrated healing of avascular meniscus tears
    Authors: Tarafder, S;Ghataure, J;Langford, D;Brooke, R;Kim, R;Eyen, SL;Bensadoun, J;Felix, JT;Cook, JL;Lee, CH;
    Bioactive materials
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC, Bioassay
  4. CD44 acts as a coreceptor for cell-specific enhancement of signaling and regulatory T cell induction by TGM1, a parasite TGF-? mimic
    Authors: van Dinther, M;Cunningham, KT;Singh, SP;White, MPJ;Campion, T;Ciancia, C;van Veelen, PA;de Ru, AH;González-Prieto, R;Mukundan, A;Byeon, CH;Staggers, SR;Hinck, CS;Hinck, AP;Dijke, PT;Maizels, RM;
    Proceedings of the National Academy of Sciences of the United States of America
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  5. Highly sensitive quantification of bacterial chondroitin in a culture based on ELISA techniques
    Authors: K Suzuki, H Kaseyama-T, S Ito
    Journal of microbiological methods, 2022-09-16;0(0):106579.
    Species: Bacteria - Escherichia coli
    Sample Types: Protein
    Applications: Surface Plasmon Resonance (SPR
  6. Oxidative damage to hyaluronan-CD44 interactions as an underlying mechanism of action of oxidative stress-inducing cancer therapy
    Authors: M Yusupov, A Privat-Mal, RM Cordeiro, H Verswyvel, P Shaw, J Razzokov, E Smits, A Bogaerts
    Redox Biology, 2021-04-11;43(0):101968.
    Species: Human
    Sample Types: Protein
    Applications: Bioassay
  7. Identification of novel CD44v6-binding peptides that block CD44v6 and deliver a pro-apoptotic peptide to tumors to inhibit tumor growth and metastasis in mice
    Authors: F Khan, S Gurung, GR Gunassekar, SMP Vadevoo, L Chi, U Permpoon, ME Haque, YK Lee, SW Lee, S Kim, B Lee
    Theranostics, 2021-01-01;11(3):1326-1344.
    Species: Human
    Sample Types: Recombinant Protein
    Applications: Bioassay
  8. Proteoglycan serglycin promotes non-small cell lung cancer cell migration through the interaction of its glycosaminoglycans with CD44
    Authors: JY Guo, CH Chiu, MJ Wang, FA Li, JY Chen
    J. Biomed. Sci., 2020-01-02;27(1):2.
    Species: Human
    Sample Types:
    Applications: Cell Culture
  9. An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides
    Authors: LL Eggink, KF Roby, R Cote, J Kenneth Ho
    J Immunother Cancer, 2018-04-17;6(1):28.
    Species: Human
    Sample Types: Peptide
    Applications: Binding Assay
  10. Role of CD44 in Regulating TLR2 Activation of Human Macrophages and Downstream Expression of Proinflammatory Cytokines
    Authors: M Qadri, S Almadani, GD Jay, KA Elsaid
    J. Immunol., 2017-12-01;0(0):.
    Species: Human
    Sample Types: Recombinant Protein
    Applications: Bioassay
  11. Soluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activity
    Sci Rep, 2016-11-28;6(0):37953.
    Applications: Bioassay
  12. CD44 Binding to Hyaluronic Acid Is Redox Regulated by a Labile Disulfide Bond in the Hyaluronic Acid Binding Site.
    Authors: Kellett-Clarke H, Stegmann M, Barclay A, Metcalfe C
    PLoS ONE, 2015-09-17;10(9):e0138137.
    Species: Human
    Sample Types: Recombinant Protein
    Applications: Bioassay
  13. Langerhans Cell-Dendritic Cell Cross-Talk via Langerin and Hyaluronic Acid Mediates Antigen Transfer and Cross-Presentation of HIV-1.
    Authors: van den Berg L, Cardinaud S, van der Aar A, Sprokholt J, de Jong M, Zijlstra-Willems E, Moris A, Geijtenbeek T
    J Immunol, 2015-07-13;195(4):1763-73.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  14. Broad spectrum activity of a lectin-like bacterial serine protease family on human leukocytes.
    Authors: Ayala-Lujan, Jorge Lu, Vijayakumar, Vidhya, Gong, Mei, Smith, Rachel, Santiago, Araceli, Ruiz-Perez, Fernando
    PLoS ONE, 2014-09-24;9(9):e107920.
    Species: Bacteria, Human
    Sample Types: Protein, Whole Cells
    Applications: Enzyme Assay, Enzyme Assay Substrate
  15. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
    Authors: Kohga K, Takehara T, Tatsumi T, Miyagi T, Ishida H, Ohkawa K, Kanto T, Hiramatsu N, Hayashi N
    Cancer Res., 2009-10-13;69(20):8050-7.
    Species: Human
    Sample Types: Whole Tissue
    Applications: Bioassay

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs
Loading...

Reviews for Recombinant Human CD44 Fc Chimera Protein, CF

Average Rating: 4.5 (Based on 2 Reviews)

5 Star
50%
4 Star
50%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Recombinant Human CD44 Fc Chimera Protein, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Recombinant Human CD44 Fc Chimera Protein, CF
By Anonymous on 06/12/2019
Application: Immunoassay Standard

Recombinant Human CD44 Fc Chimera Protein, CF
By Anonymous on 01/30/2019
Application: Immunoassay Standard